Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Traws Pharma (TRAW) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to -$0.34.

  • Traws Pharma's EPS (Basic) rose 7718.12% to -$0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.63, marking a year-over-year increase of 9504.71%. This contributed to the annual value of -$35.21 for FY2024, which is 5602.09% down from last year.
  • According to the latest figures from Q3 2025, Traws Pharma's EPS (Basic) is -$0.34, which was up 7718.12% from -$0.11 recorded in Q2 2025.
  • In the past 5 years, Traws Pharma's EPS (Basic) registered a high of $2.17 during Q1 2025, and its lowest value of -$20.52 during Q2 2024.
  • Moreover, its 5-year median value for EPS (Basic) was -$0.27 (2022), whereas its average is -$2.81.
  • Per our database at Business Quant, Traws Pharma's EPS (Basic) crashed by 1016000.0% in 2024 and then surged by 13665.54% in 2025.
  • Traws Pharma's EPS (Basic) (Quarter) stood at -$0.22 in 2021, then dropped by 22.67% to -$0.27 in 2022, then crashed by 1837.94% to -$5.31 in 2023, then tumbled by 159.56% to -$13.79 in 2024, then surged by 97.54% to -$0.34 in 2025.
  • Its EPS (Basic) was -$0.34 in Q3 2025, compared to -$0.11 in Q2 2025 and $2.17 in Q1 2025.